http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5281196-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44aa4e99100648b8871301161201ded9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2121-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-375
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-375
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
filingDate 1992-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1994-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0b5352fd942a021c6d57594fe9c8b97
publicationDate 1994-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-5281196-A
titleOfInvention Skin treatment composition and method of use
abstract A composition and method of applying a composition of (a) between about 10 and 15 percent vitamin C, plus or minus 10 percent, by weight to volume, (b) a viscosity agent, and (c) water as the remainder of the composition to healthy surface tissue overlying unhealthy tissue to be treated by radiation therapy for thereby abating dermatitis, mucositis, and esophagitis normally attendant with radiation therapy, the method comprising the steps of identifying the healthy surface tissue in the path of a radiation beam proposed to treat the unhealthy tissue, the identified healthy tissue being pretreated with vitamin C to increase the concentration of ascorbic acid in the identified healthy tissue; applying the composition to the identified healthy tissue; waiting a period of time of about at least one hour prior to radiation therapy so as to allow the vitamin C of the composition to increase the concentration of ascorbic acid in the healthy tissue whereby free radicals from ensuing radiation therapy are scavenged by the increased concentration of ascorbic acid in the healthy tissue; applying therapeutic radiation to the pretreated healthy tissue and the unhealthy tissue in a predetermined target dosage so that unhealthy tissue will be destroyed but so that the increased concentration of ascorbic acid in the healthy tissue will scavenge free radicals from the applied radiation; and scavenging free radicals from the applied radiation by the increased concentration of ascorbic acid in the healthy tissue so that dermatitis, mucositis, and esophagitis normally resulting from radiation therapy are abated.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007178058-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005065091-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6074647-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007077220-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6420420-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6221904-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004002540-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0189520-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5484816-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6749596-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007269534-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6608106-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5804594-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-1109540-C
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6447499-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2781156-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0189520-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6024941-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11058743-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0004878-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6184247-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5747006-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9704830-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6103267-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7033606-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6565895-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9308234-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6358539-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6676977-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10406200-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005129787-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6262111-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5972999-A
priorityDate 1992-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4670471-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4686235-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4617187-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4975272-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4707354-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5078129-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4861783-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4578390-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID99037
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID99037
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440667
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226447355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394110
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135874386

Total number of triples: 66.